CCR8 and hepatocellular carcinoma: In the present study, we attempted to determine the potential involvement of CCR8+ Tregs in human HCC tissues and to examine the anticancer effect and the underlying molecular mechanisms of the CCR8 antagonistic antibody, IPG0521m, in murine liver cancer model.